
-
Kenya's economy faces climate change risks: World Bank
-
World scrambles to temper Trump tariffs: White House
-
Torrential rains kill dozens in DR Congo capital
-
Vietnam seeks US tariff delay as economic growth slows in first quarter
-
UK readies to protect industry as US tariffs upend global order: Starmer
-
Vietnam economic growth slows in first quarter as US tariffs loom
-
The scientist rewriting DNA, and the future of medicine
-
'Anxious': US farmers see tariffs threaten earnings
-
Nostalgia fuels UK boom in vintage video game repairs
-
Snappy birthday: Germany's Leica camera turns 100
-
India's Modi in Sri Lanka for defence and energy deals
-
Fractious Republicans seek unity over Trump tax cuts
-
Trump's global tariff takes effect in dramatic US trade shift
-
'I don't have a voice in my head': Life with no inner monologue
-
Lula admits 'still a lot to do' for Indigenous Brazilians
-
California to defy Trump's tariffs to allay global trade fears
-
Sean 'Diddy' Combs faces more charges ahead of criminal trial
-
Intercommunal violence kills dozens in central Nigeria
-
Trump goads China as global trade war escalates
-
How can the EU respond to Trump tariffs?
-
Canada loses jobs for first time in 3 years as US tariffs bite
-
Nations divided ahead of decisive week for shipping emissions
-
US job growth strong in March but Trump tariff impact still to come
-
Stocks, oil slump as China retaliates and Trump digs in heels
-
US hiring beats expectations in March as tariff uncertainty brews
-
Where things stand in the US-China trade war
-
UK spy agency MI5 reveals fruity secrets in new show
-
Taiwan earmarks $2.7 bn to help industries hit by US tariffs
-
Greece nixes Acropolis shoot for 'Poor Things' director
-
Trump unveils first $5 million 'gold card' visa
-
BP chairman to step down after energy strategy reset
-
Indian patriotic movie 'icon' Manoj Kumar dies aged 87
-
Pacific nations perplexed, worried by Trump tariffs
-
Prominent US academic facing royal insult charge in Thailand
-
Yana, a 130,000-year-old baby mammoth, goes under the scalpel
-
Crops under threat as surprise March heatwave hits Central Asia: study
-
Japan PM says Trump tariffs a 'national crisis'
-
'It's gone': conservation science in Thailand's burning forest
-
EU leaders push for influence at Central Asia summit
-
Asian stocks extend global rout after Trump's shock tariff blitz
-
German industry grapples with AI at trade fair
-
Where Trump's tariffs could hurt Americans' wallets
-
Trump tariffs on Mexico: the good, the bad, the unknown
-
With tariff war, Trump also reshapes how US treats allies
-
Penguin memes take flight after Trump tariffs remote island
-
Tom Cruise pays tribute to Val Kilmer
-
'Everyone worried' by Trump tariffs in France's champagne region
-
UK avoids worst US tariffs post-Brexit, but no celebrations
-
Canada imposing 25% tariff on some US auto imports
-
Lesotho, Africa's 'kingdom in the sky' jolted by Trump
RELX | -6.81% | 48.16 | $ | |
SCS | -0.56% | 10.68 | $ | |
NGG | -5.25% | 65.93 | $ | |
BCC | 0.85% | 95.44 | $ | |
CMSC | 0.13% | 22.29 | $ | |
RYCEF | -18.79% | 8.25 | $ | |
VOD | -10.24% | 8.5 | $ | |
RBGPF | 100% | 69.02 | $ | |
JRI | -7.19% | 11.96 | $ | |
RIO | -6.88% | 54.67 | $ | |
CMSD | 0.7% | 22.83 | $ | |
BCE | 0.22% | 22.71 | $ | |
GSK | -6.79% | 36.53 | $ | |
AZN | -7.98% | 68.46 | $ | |
BTI | -5.17% | 39.86 | $ | |
BP | -10.43% | 28.38 | $ |

Canadian fund drops bid for Spanish pharma firm Grifols
Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following disagreement over its valuation.
Brookfield and the Grifols family, which owns about a third of the Barcelona-based company that makes medicine derived from blood plasma, have since July been in talks to take it private.
Earlier this month Brookfield made a 6.45-billion-euro bid for Grifols, offering a tentative non-binding price of 10.50 euros ($11) per share.
Grifols swiftly rejected the bid, saying it "significantly underestimated the fundamental prospects and long-term potential" of the company.
In a statement sent to Spanish stock market regulator CNMV, Brookfield said it was "not in a position to continue with a potential offer" for Grifols.
Grifols said its board agreed that "it is not feasible that the transaction goes ahead" and remains focused on "improving the company's long-term value".
Its share price plunged in January after US hedge fund Gotham City released a research note accusing the company of "manipulating" its reported debt and operational results to "artificially reduce" its debt ratio, and therefore its financing costs.
Grifols has repeatedly denied the allegations.
Gotham City is a prominent "short-seller" hedge fund that borrows stock in a company and sells it, hoping to buy it back cheaper to return it to the lender and pocket the difference.
Grifols traces its history back to 1909, first as a blood analysis and transfusion laboratory before specialising in products derived from blood plasma.
It is present in more than 30 countries including Australia, the United States and Japan. It posted revenue of 6.6 billion euros in 2023, a 10.9 percent increase over the previous year.
Y.Tengku--CPN